Michael A Postow

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Dirk Schadendorf, Reinhard Dummer, Paolo A Ascierto, 2015, The New England journal of medicine.

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

M. Postow, Michael A Postow, Claire F Friedman, 2016, JAMA oncology.

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Antoni Ribas, Caroline Robert, Anthony M Joshua, 2014, The Lancet.

Immune modulation in cancer with antibodies.

J. Wolchok, J. Allison, M. Callahan, 2014, Annual review of medicine.

Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes.

C. Barker, M. Postow, Christopher A Barker, 2014, International journal of radiation oncology, biology, physics.